Akcea Therapeutics Inc. appointed Richard Moscicki to the Cambridge, Mass.-based biopharmaceutical company's board.
Moscicki is the executive vice president for science and regulatory advocacy and the chief medical officer at Pharmaceutical Research and Manufacturers of America, a trade group representing companies in the pharmaceutical industry in the U.S.
He is also the former deputy center director for science operations for the U.S. Food and Drug Administration's Center for Drug Evaluation and Research.
Moscicki is expected to help the company, an affiliate of Ionis Pharmaceuticals Inc., as it prepares for two rare disease drug launches under regulatory review in the U.S., Canada and the EU.
